Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	GTPase activator activity	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ARHGAP5 ARFGAP1	4.29e-06	279	197	13	GO:0005096
GeneOntologyMolecularFunction	enzyme activator activity	ERCC5 PSME4 TBC1D3I TBC1D3G BTRC TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ARHGAP5 PTPA IGF2 EGFR ARFGAP1 CWF19L1	8.24e-06	656	197	20	GO:0008047
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	MYCBP2 FARP2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B CCDC88C ARHGAP5 ARFGAP1 TNK2	1.21e-05	507	197	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	MYCBP2 FARP2 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B CCDC88C ARHGAP5 ARFGAP1 TNK2	1.21e-05	507	197	17	GO:0030695
GeneOntologyMolecularFunction	calcium ion binding	FAT1 FAT2 EFHC1 CDH20 SULF1 NID1 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 ADAMTS13 PKD1L3 PADI6 CDH2 CDH12	5.44e-05	749	197	20	GO:0005509
GeneOntologyMolecularFunction	beta-catenin binding	BCL9 CDH20 BTRC TJP1 CDH2 TCF7L1 CDH12	1.90e-04	120	197	7	GO:0008013
GeneOntologyMolecularFunction	transcription coactivator activity	BCL9 KMT2C BRD8 TOX3 MED26 DTX1 POU2AF1 XPC KMT2D KAT6B TOX2	2.21e-04	303	197	11	GO:0003713
GeneOntologyMolecularFunction	transcription coregulator activity	BCORL1 BCL9 KMT2C RCOR1 BRD8 TOX3 MED26 DTX1 PHF12 POU2AF1 XPC SF1 KMT2D KAT6B TOX2	4.80e-04	562	197	15	GO:0003712
GeneOntologyMolecularFunction	cadherin binding	ATXN2L HNRNPK CDH20 TJP2 FLNA RTN4 EGFR TJP1 EIF2A CDH2 CDH12	5.70e-04	339	197	11	GO:0045296
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	2.85e-09	187	194	14	GO:0007156
GeneOntologyBiologicalProcess	activation of GTPase activity	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	6.60e-09	109	194	11	GO:0090630
GeneOntologyBiologicalProcess	cell-cell adhesion	EPHB3 TRAF6 ADAM9 FAT1 FAT2 CDH20 TJP2 PLEKHA7 AP3D1 FLNA DTX1 TBX21 XBP1 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 GPAM PCDHA6 PCDHA4 PCDHA2 PCDHA1 CLDN2 IGF2 EGFR TJP1 PARD3 CDH2 CDH12	9.16e-08	1077	194	30	GO:0098609
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CLDN2 CDH2 CDH12	2.96e-07	313	194	15	GO:0098742
GeneOntologyBiologicalProcess	cell-cell junction organization	CDH20 ABCC8 TJP2 PLEKHA7 FLNA FKRP CLDN2 TJP1 ALOXE3 PARD3 CDH2 CDH12	3.92e-06	246	194	12	GO:0045216
GeneOntologyBiologicalProcess	positive regulation of GTPase activity	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	2.08e-05	244	194	11	GO:0043547
GeneOntologyBiologicalProcess	regulation of GTPase activity	EPHB3 TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	8.30e-05	335	194	12	GO:0043087
GeneOntologyBiologicalProcess	regulation of blood-brain barrier permeability	ABCC8 TJP2 TJP1	9.36e-05	10	194	3	GO:1905603
GeneOntologyBiologicalProcess	cell-cell adhesion mediated by cadherin	CDH20 PLEKHA7 TJP1 CDH2 CDH12	1.05e-04	50	194	5	GO:0044331
GeneOntologyBiologicalProcess	cell junction organization	EPHB3 GPHN DHX36 MYCBP2 HNRNPK CDH20 ABCC8 TJP2 PLEKHA7 FLNA FMR1 ABI3BP FKRP RTN4 ROR2 CLDN2 SHANK2 TJP1 ALOXE3 PARD3 CDH2 CDH12	1.31e-04	974	194	22	GO:0034330
GeneOntologyCellularComponent	anchoring junction	GAK EPPK1 ADAM9 ZYX HNRNPK GJA3 FAP FAT1 FAT2 CDH20 TJP2 PLEKHA7 APBB1IP FLNA FLNC RTN4 PCDHA12 LAP3 CLDN2 CCDC88C EGFR TJP1 TNK2 PARD3 CDH2 CDH12	1.59e-06	976	196	26	GO:0070161
GeneOntologyCellularComponent	adherens junction	ZYX FAT2 CDH20 TJP2 PLEKHA7 TJP1 TNK2 PARD3 CDH2 CDH12	3.31e-05	212	196	10	GO:0005912
GeneOntologyCellularComponent	cell-cell junction	EPPK1 ZYX GJA3 FAT1 FAT2 CDH20 TJP2 PLEKHA7 FLNA PCDHA12 CLDN2 CCDC88C TJP1 TNK2 PARD3 CDH2 CDH12	4.44e-05	591	196	17	GO:0005911
GeneOntologyCellularComponent	cytoplasmic stress granule	DHX36 ATXN2L HNRNPK UBAP2L PRRC2C FMR1	2.90e-04	96	196	6	GO:0010494
GeneOntologyCellularComponent	cell-substrate junction	GAK EPPK1 ADAM9 ZYX HNRNPK FAP FAT1 APBB1IP FLNA FLNC LAP3 EGFR CDH2	2.95e-04	443	196	13	GO:0030055
GeneOntologyCellularComponent	trans-Golgi network	PI4K2B PCSK5 ATP7A KIAA0319L AP3D1 CHAC1 FLNA SLC66A2 LAP3 VPS53	6.51e-04	306	196	10	GO:0005802
GeneOntologyCellularComponent	apical junction complex	EPPK1 TJP2 PLEKHA7 CLDN2 CCDC88C TJP1 PARD3	7.41e-04	158	196	7	GO:0043296
GeneOntologyCellularComponent	focal adhesion	GAK ADAM9 ZYX HNRNPK FAP FAT1 APBB1IP FLNA FLNC LAP3 EGFR CDH2	7.97e-04	431	196	12	GO:0005925
MousePheno	lethality during fetal growth through weaning, complete penetrance	GPHN PDE2A GAK TRAF6 ERCC5 ATP7A STAG1 MYCBP2 BCKDHB NEB MEFV KMT2C RCOR1 FAT1 HECW2 TMEM132A FOXC1 FLNA FLNC ADAMTS3 FKRP ROR2 ARX HPDL ARHGAP5 HHIP IGF2 EGFR ALOXE3 OGA CEP57 TCF7L1	2.01e-06	1269	146	32	MP:0011111
MousePheno	multiple persisting craniopharyngeal ducts	TRAF6 DMXL2 SLC25A20 ADAMTS3	1.43e-05	15	146	4	MP:0013968
MousePheno	abnormal pituitary diverticulum morphology	TRAF6 FOXC1 DMXL2 SLC25A20 ADAMTS3	3.37e-05	36	146	5	MP:0003817
MousePheno	abnormal adenohypophysis development	TRAF6 FOXC1 DMXL2 SLC25A20 ADAMTS3	4.41e-05	38	146	5	MP:0013337
MousePheno	abnormal pituitary gland development	TRAF6 FOXC1 DMXL2 SLC25A20 ADAMTS3	7.23e-05	42	146	5	MP:0003816
Domain	Cadherin_CS	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	7.18e-12	109	194	14	IPR020894
Domain	CADHERIN_1	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	1.18e-11	113	194	14	PS00232
Domain	Cadherin	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	1.18e-11	113	194	14	PF00028
Domain	CADHERIN_2	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	1.34e-11	114	194	14	PS50268
Domain	-	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	1.34e-11	114	194	14	2.60.40.60
Domain	CA	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	1.51e-11	115	194	14	SM00112
Domain	Cadherin-like	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	1.70e-11	116	194	14	IPR015919
Domain	Cadherin	FAT1 FAT2 CDH20 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CDH2 CDH12	2.15e-11	118	194	14	IPR002126
Domain	TBC	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	6.70e-11	49	194	10	SM00164
Domain	Cadherin_tail	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.13e-10	37	194	9	PF15974
Domain	Cadherin_CBD	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.13e-10	37	194	9	IPR031904
Domain	RabGAP-TBC	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.53e-10	53	194	10	PF00566
Domain	Rab-GTPase-TBC_dom	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	2.26e-10	55	194	10	IPR000195
Domain	TBC_RABGAP	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	2.26e-10	55	194	10	PS50086
Domain	Cadherin_2	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.26e-08	65	194	9	PF08266
Domain	Cadherin_N	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.26e-08	65	194	9	IPR013164
Domain	HMG_box	HMG20B KMT2C TOX3 KMT2D TOX2 TCF7L1	1.78e-05	53	194	6	PF00505
Domain	HMG	HMG20B KMT2C TOX3 KMT2D TOX2 TCF7L1	1.98e-05	54	194	6	SM00398
Domain	HMG_box_dom	HMG20B KMT2C TOX3 KMT2D TOX2 TCF7L1	5.77e-05	65	194	6	IPR009071
Domain	TMEM183	TMEM183A TMEM183BP	1.07e-04	2	194	2	IPR026509
Domain	Beta-TrCP_D	BTRC FBXW11	1.07e-04	2	194	2	IPR021977
Domain	Beta-TrCP_D	BTRC FBXW11	1.07e-04	2	194	2	PF12125
Domain	Beta-TrCP_D	BTRC FBXW11	1.07e-04	2	194	2	SM01028
Domain	Filamin	MYCBP2 FLNA FLNC	1.71e-04	11	194	3	PF00630
Domain	FILAMIN_REPEAT	MYCBP2 FLNA FLNC	1.71e-04	11	194	3	PS50194
Domain	Filamin/ABP280_rpt	MYCBP2 FLNA FLNC	1.71e-04	11	194	3	IPR001298
Domain	Filamin/ABP280_repeat-like	MYCBP2 FLNA FLNC	1.71e-04	11	194	3	IPR017868
Domain	Catenin_binding_dom	CDH20 CDH2 TCF7L1 CDH12	2.19e-04	29	194	4	IPR027397
Domain	-	CDH20 CDH2 TCF7L1 CDH12	2.19e-04	29	194	4	4.10.900.10
Domain	-	HMG20B TOX3 KMT2D TOX2 TCF7L1	2.62e-04	55	194	5	1.10.30.10
Domain	ZO	TJP2 TJP1	3.20e-04	3	194	2	IPR005417
Domain	TEA_1	TEAD1 TEAD4	6.35e-04	4	194	2	PS00554
Domain	TEA_2	TEAD1 TEAD4	6.35e-04	4	194	2	PS51088
Domain	TEA	TEAD1 TEAD4	6.35e-04	4	194	2	PF01285
Domain	TEA/ATTS_dom	TEAD1 TEAD4	6.35e-04	4	194	2	IPR000818
Domain	TEF_metazoa	TEAD1 TEAD4	6.35e-04	4	194	2	IPR016361
Domain	TEA	TEAD1 TEAD4	6.35e-04	4	194	2	SM00426
Domain	FYrich_C	KMT2C KMT2D	1.05e-03	5	194	2	IPR003889
Domain	FYrich_N	KMT2C KMT2D	1.05e-03	5	194	2	IPR003888
Domain	FYRC	KMT2C KMT2D	1.05e-03	5	194	2	SM00542
Domain	FYRN	KMT2C KMT2D	1.05e-03	5	194	2	SM00541
Domain	TMEM132D_N	TMEM132B TMEM132A	1.05e-03	5	194	2	PF15705
Domain	TMEM132D_C	TMEM132B TMEM132A	1.05e-03	5	194	2	PF15706
Domain	TMEM132_M	TMEM132B TMEM132A	1.05e-03	5	194	2	IPR031437
Domain	TMEM132_C	TMEM132B TMEM132A	1.05e-03	5	194	2	IPR031436
Domain	TMEM132_N	TMEM132B TMEM132A	1.05e-03	5	194	2	IPR031435
Domain	TMEM132	TMEM132B TMEM132A	1.05e-03	5	194	2	IPR026307
Domain	TMEM132	TMEM132B TMEM132A	1.05e-03	5	194	2	PF16070
Domain	FYRN	KMT2C KMT2D	1.05e-03	5	194	2	PF05964
Domain	FYRC	KMT2C KMT2D	1.05e-03	5	194	2	PF05965
Domain	FYRC	KMT2C KMT2D	1.05e-03	5	194	2	PS51543
Domain	FYRN	KMT2C KMT2D	1.05e-03	5	194	2	PS51542
Domain	EPHD	KMT2C KMT2D RAI1	1.47e-03	22	194	3	PS51805
Domain	GF_recep_IV	PCSK5 EGFR	1.57e-03	6	194	2	PF14843
Domain	GF_recep_IV	PCSK5 EGFR	1.57e-03	6	194	2	IPR032778
Domain	Ephrin_rec_like	EPHB3 PCSK5 TG	2.14e-03	25	194	3	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB3 PCSK5 TG	2.14e-03	25	194	3	IPR011641
Domain	Cadherin_C	CDH20 CDH2 CDH12	2.14e-03	25	194	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH20 CDH2 CDH12	2.14e-03	25	194	3	IPR000233
Pathway	WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME	TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B	7.05e-07	99	143	9	M46448
Pathway	WP_HIPPO_SIGNALING_REGULATION	CDH20 TEAD1 TEAD4 EGFR CDH2 TCF7L1 CDH12	6.11e-05	98	143	7	M39830
Pubmed	TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12.	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.63e-25	11	199	11	16863688
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.66e-17	15	199	9	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.28e-16	17	199	9	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.55e-16	18	199	9	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.55e-16	18	199	9	10662547
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	6.65e-15	24	199	9	24698270
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	3.44e-14	28	199	9	15347688
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4	5.84e-14	11	199	7	9655502
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	FAT2 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.18e-11	72	199	10	10380929
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L ERCC5 MYCBP2 BCL9 ZYX HNRNPK BRD8 UBAP2L POP1 TJP2 FLNA EP400 PHF12 XPC HNRNPUL1 ATAD2 SF1 KMT2D EGFR PRICKLE3 ARFGAP1 PARD3 KAT6B OGA	2.23e-11	774	199	24	15302935
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	FAT2 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.36e-11	77	199	10	10835267
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA13 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4	2.92e-11	12	199	6	10612399
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	FAT2 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	3.48e-11	80	199	10	10716726
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	3.89e-11	57	199	9	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	4.58e-11	58	199	9	30377227
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GPHN ATXN2L GAK MYCBP2 ZYX HNRNPK KMT2C BRD8 UBAP2L PRRC2C TJP2 FLNA CDV3 EP400 TEAD1 TEAD4 KMT2D TJP1 ARFGAP1 PARD3	6.97e-11	549	199	20	38280479
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.02e-10	68	199	9	11230163
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	4.39e-10	74	199	9	10817752
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	4.97e-10	75	199	9	15372022
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 PCSK5 PDE2A EPPK1 PCNX3 MYCBP2 KIAA0319L BCL9 KMT2C FAT1 PSME4 CSAD TMEM132A TIMM22 AP3D1 SEMA6C FLNA FLNC EP400 PHF12 ATP13A2 CCDC88C KMT2D SHANK2 TNK2 RAI1	1.19e-09	1105	199	26	35748872
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	ATXN2L EPPK1 UBAP2L PRRC2C AP3D1 FLNA RTN4 ZDBF2 SF1 EGFR TJP1 ARFGAP1 NBR1	3.37e-09	256	199	13	33397691
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	FLNA FLNC DTX1 RTN4 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA2 PCDHA1 SHANK2 PRICKLE3 EIF3D	7.95e-09	329	199	14	17474147
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DHX36 MLEC KMT2C PSME4 SULF1 HECW2 SEMA6C EP400 PHF12 RTN4 NUAK2 DAAM1 KAT6B OGA CEP57 NBR1 RAI1	1.27e-08	529	199	17	14621295
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	CHAC1 DTX1 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.71e-08	193	199	11	22589738
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	3.08e-08	119	199	9	28625976
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	GAK EPPK1 GALNS MLEC MYCBP2 MARS1 ADAM9 L2HGDH ZYX NDUFS8 FAT1 UBAP2L PRRC2C CLPTM1 POP1 AP3D1 FLNA RTN4 POLR2C HNRNPUL1 DARS2 PTPA EGFR TJP1 ARFGAP1 NBR1	3.11e-08	1297	199	26	33545068
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	DHX36 ATXN2L UBAP2L TJP2 DMXL2 CDV3 HNRNPUL1 EGFR PARD3	8.10e-08	133	199	9	15144186
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPHN PDE2A MYCBP2 ADAM9 WDR81 BCL9 TMEM132B HNRNPK EPM2AIP1 RCOR1 UBAP2L PRRC2C DMXL2 FMR1 CCDC88C SHANK2 TJP1 SPHKAP PARD3 CDH2 RAI1	1.86e-07	963	199	21	28671696
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPHN DHX36 ATXN2L PDE2A GAK MARS1 HNRNPK NDUFS8 GJA3 UBAP2L PRRC2C HECW2 TJP2 MAP7D2 PLEKHA7 AP3D1 FLNA FLNC DMXL2 FMR1 RTN4 NUAK2 ARHGAP5 SHANK2 TJP1 CDH2	2.12e-07	1431	199	26	37142655
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	TBC1D3G TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3B	2.35e-07	74	199	7	16625196
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPHN ATXN2L GAK MARS1 ZYX HNRNPK UBAP2L PRRC2C AP3D1 FLNA CDV3 EP400 RTN4 HNRNPUL1 SF1 TJP1 ARFGAP1 EIF3D EIF2A OGA	4.91e-07	934	199	20	33916271
Pubmed	Endfoot regeneration restricts radial glial state and prevents translocation into the outer subventricular zone in early mammalian brain development.	PLEKHA7 TJP1 PARD3 CDH2	7.14e-07	13	199	4	31871317
Pubmed	PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.	TBC1D3F TBC1D3 TBC1D3D	7.35e-07	4	199	3	12359748
Pubmed	Identification of novel sequences in the repertoire of hypervariable TRE17 genes from immortalized nonmalignant and malignant human keratinocytes.	TBC1D3F TBC1D3 TBC1D3D	7.35e-07	4	199	3	8406013
Pubmed	Interaction network of human early embryonic transcription factors.	BCORL1 BCL9 HMG20B KMT2C RCOR1 EP400 PHF12 TEAD1 KMT2D ZNF746 CDH2 RAI1	9.84e-07	351	199	12	38297188
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ATXN2L MYCBP2 ZYX HNRNPK UBAP2L PRRC2C TJP2 FLNA FLNC CDV3 FMR1 RTN4 XPC SF1 TJP1 EIF3D EIF2A	1.07e-06	724	199	17	36232890
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	GAK RHBDD2 ZYX UBAP2L PRRC2C FLNA FLNC CDV3 RTN4 ROR2 ZDBF2 EGFR TJP1 ARFGAP1 EIF2A	1.12e-06	568	199	15	37774976
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PCSK5 DHX36 ADAM9 RHBDD2 L2HGDH FARP2 TMEM62 PSME4 PRRC2C POP1 AP3D1 DMXL2 FMR1 RTN4 GPAM CWF19L1	1.22e-06	650	199	16	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DHX36 ATXN2L EPPK1 MYCBP2 UBAP2L PRRC2C POP1 TJP2 FLNA FLNC FMR1 HNRNPUL1 ATAD2 TJP1 EIF3D RAI1	1.30e-06	653	199	16	22586326
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MLEC PCNX3 MARS1 RHBDD2 NDUFS8 HMG20B FARP2 KMT2C BRD8 POP1 PLEKHA7 SPTY2D1 EP400 PHF12 POLR2C XPC API5 SRBD1 ATAD2 SHANK2 MPHOSPH8 EIF3D DAAM1 PARD3 EIF2A	1.71e-06	1497	199	25	31527615
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	TBC1D3 TBC1D3D TBC1D3C	1.83e-06	5	199	3	12604796
Pubmed	Human TRE17 oncogene is generated from a family of homologous polymorphic sequences by single-base changes.	TBC1D3F TBC1D3 TBC1D3D	1.83e-06	5	199	3	8471161
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ZYX HNRNPK UBAP2L MED26 FLNA FLNC CDV3 EP400 RTN4 SF1 TJP1 ARFGAP1 ZMYM5	1.94e-06	444	199	13	34795231
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	DHX36 ATXN2L HNRNPK UBAP2L PRRC2C FMR1 API5 SF1 TJP1 EIF3D	2.65e-06	258	199	10	37794589
Pubmed	The non-receptor tyrosine kinase Ack1 regulates the fate of activated EGFR by inducing trafficking to the p62/NBR1 pre-autophagosome.	EGFR TNK2 NBR1	3.64e-06	6	199	3	24413169
Pubmed	PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.	BTRC TEAD4 PARD3	3.64e-06	6	199	3	26116754
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	ATXN2L ZYX HNRNPK UBAP2L PRRC2C POP1 FLNA FLNC FMR1 API5 HNRNPUL1 SRBD1 CCDC88C EIF3D	4.03e-06	551	199	14	34728620
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	DHX36 ATXN2L HNRNPK UBAP2L TJP2 PLEKHA7 FLNA FMR1 HNRNPUL1 TJP1	4.52e-06	274	199	10	34244482
Pubmed	Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.	ATXN2L RHBDD2 MEFV RTN4 ZDBF2 MINDY2 TJP1	4.97e-06	116	199	7	30652415
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PDE2A TRAF6 MLEC STAG1 MYCBP2 ADAM9 KIAA0319L HNRNPK SULF1 BTRC FBXW11 DMXL2 POLR2C XPC HNRNPUL1 SF1 ARHGAP5 HEATR6 HEY1 TJP1 EIF3D ZMYM5	5.08e-06	1285	199	22	35914814
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ATXN2L ZYX HNRNPK TJP2 PLEKHA7 FLNA RTN4 ARHGAP5 SHANK2 EGFR TJP1 DAAM1 PARD3 EIF2A	5.36e-06	565	199	14	25468996
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	BCORL1 HNRNPK NDUFS8 HMG20B KMT2C RCOR1 BRD8 POP1 SPTY2D1 FOXC1 FMR1 EP400 PHF12 POLR2C XPC TEAD1 HNRNPUL1 SRBD1 SF1 KMT2D MPHOSPH8 RAI1	5.67e-06	1294	199	22	30804502
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	ATP7A PCNX3 MYCBP2 ADAM9 KIAA0319L RHBDD2 BCL9 MAP7D2 SPTY2D1 API5 HNRNPUL1 EGFR HEY1 TJP1 ARFGAP1 EIF3D EIF2A ATP1B3 CWF19L1	6.01e-06	1007	199	19	34597346
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	ADAM9 ZYX HNRNPK FAP FAT1 FLNA FLNC LAP3 EGFR CDH2	6.39e-06	285	199	10	21423176
Pubmed	Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration.	HNRNPK FLNA RTN4 EGFR TJP1	6.61e-06	46	199	5	35022314
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	STAG1 ZYX HNRNPK NDUFS8 UBAP2L FLNA DMXL2 RTN4 API5 DARS2 TJP1 EIF3D EIF2A	6.72e-06	498	199	13	36634849
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	EPHB3 EPPK1 MYCBP2 AP3D1 FOXC1 SEMA6C FMR1 RTN4 POLR2C EGFR PARD3	7.73e-06	358	199	11	32460013
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	GAK MARS1 HNRNPK EPM2AIP1 PRRC2C TJP2 FLNA FLNC CDV3 DARS2 TJP1	8.15e-06	360	199	11	33111431
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	PI4K2B GAK TMEM183A MLEC MARS1 L2HGDH NDUFS8 UBAP2L PRRC2C POP1 TJP2 AP3D1 BTRC FBXW11 FLNA RTN4 MAP3K14 HNRNPUL1 SF1 ARFGAP1 EIF3D ATP1B3 VPS53	9.44e-06	1440	199	23	30833792
Pubmed	Lulu2 regulates the circumferential actomyosin tensile system in epithelial cells through p114RhoGEF.	TJP2 TJP1 PARD3	1.01e-05	8	199	3	22006950
Pubmed	HSPB7 prevents cardiac conduction system defect through maintaining intercalated disc integrity.	FLNA FLNC CDH2	1.01e-05	8	199	3	28827800
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	GPHN ATXN2L EPPK1 MARS1 UBAP2L PRRC2C RTN4 API5 HNRNPUL1 LAP3 SF1 DARS2 EIF3D EIF2A	1.20e-05	607	199	14	39147351
Pubmed	Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.	ATXN2L UBAP2L PRRC2C FLNA CDV3	1.47e-05	54	199	5	25631074
Pubmed	The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.	TJP2 TJP1 PARD3	1.51e-05	9	199	3	21074722
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	ATXN2L EPPK1 MARS1 UBAP2L PRRC2C FMR1 HNRNPUL1 ATAD2 EIF3D EIF2A	1.52e-05	315	199	10	26777405
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ATXN2L ATP7A MLEC MARS1 HNRNPK UBAP2L PRRC2C AP3D1 RTN4 ROR2 EGFR ARFGAP1 PARD3 EIF2A ATP1B3	1.58e-05	708	199	15	39231216
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	DHX36 ATXN2L TMEM183A MYCBP2 RCOR1 UBAP2L PRRC2C FMR1 POLR2C TMEM183BP HNRNPUL1 EGFR	1.61e-05	462	199	12	31138677
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF444 MYCBP2 MARS1 L2HGDH FARP2 KMT2C UBAP2L ABCC8 TOX3 FBXW11 ROR2 TMEM183BP SGK2 IGF2 SHANK2 EGFR TJP1 TNK2 DAAM1 PARD3 KAT6B NBR1 RAI1	1.61e-05	1489	199	23	28611215
Pubmed	Phrenic-specific transcriptional programs shape respiratory motor output.	GPHN CDH20 CDH2 CDH12	1.65e-05	27	199	4	31944180
Pubmed	The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression.	ATXN2L UBAP2L PRRC2C TJP2 FLNA FMR1	2.09e-05	97	199	6	37151849
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ATXN2L STAG1 HNRNPK UBAP2L PRRC2C NID1 AP3D1 BTRC FBXW11 FMR1 ARHGAP5 PARD3	2.11e-05	475	199	12	31040226
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	GPHN ATXN2L MARS1 ZYX UBAP2L PRRC2C FLNC API5 LAP3 SF1 EIF3D	2.11e-05	399	199	11	35987950
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ATXN2L MLEC MARS1 ADAM9 RHBDD2 HMOX1 HNRNPK EPM2AIP1 CLPTM1 TMEM132A AP3D1 FLNA FLNC RTN4 XPC SF1 PRICKLE3 TJP1 ATP1B3 CDH2	2.13e-05	1203	199	20	29180619
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATXN2L MYCBP2 MARS1 BCORL1 BCL9 ZYX HNRNPK HMG20B KMT2C RCOR1 PRRC2C FLNA EP400 PHF12 HNRNPUL1 SF1 KMT2D EIF2A RAI1	2.13e-05	1103	199	19	34189442
Pubmed	β-TrCP-mediated IRAK1 degradation releases TAK1-TRAF6 from the membrane to the cytosol for TAK1-dependent NF-κB activation.	TRAF6 BTRC FBXW11	2.15e-05	10	199	3	22851693
Pubmed	FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry.	GPHN FMR1 CDH2	2.15e-05	10	199	3	25402856
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	DHX36 EPPK1 ERCC5 MARS1 HNRNPK NDUFS8 UBAP2L PRRC2C POP1 AP3D1 FLNA CDV3 POLR2C HNRNPUL1 SF1 DARS2 EGFR TJP1 EIF3D EIF2A NBR1 CWF19L1	2.25e-05	1415	199	22	28515276
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MYCBP2 BCORL1 ZYX RCOR1 BRD8 UBAP2L MED26 FOXC1 EP400 XPC SRBD1 ATAD2 MPHOSPH8 RAI1	2.34e-05	645	199	14	25281560
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	DHX36 RCOR1 POP1 SPTY2D1 FMR1 EP400 XPC KMT2D HEATR6 EIF3D VPS53	2.71e-05	410	199	11	26949251
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	MARS1 ZYX KMT2C CSAD BTRC FBXW11 RTN4 POLR2C MAP3K14 MYOZ3 ATP13A2 LAP3 CCDC88C IGF2 ZNF746 ARFGAP1 EIF3D OGA RAI1	2.76e-05	1124	199	19	21900206
Pubmed	Fbxo45 inhibits calcium-sensitive proteolysis of N-cadherin and promotes neuronal differentiation.	MYCBP2 BTRC CDH2	2.94e-05	11	199	3	25143387
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	DHX36 ATXN2L STAG1 AP3D1 EP400 SRBD1 SF1 DARS2 KMT2D KAT6B	2.99e-05	341	199	10	32971831
Pubmed	CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.	POU2AF1 CD22	3.26e-05	2	199	2	12207332
Pubmed	The zonula occludens protein family regulates the hepatic barrier system in the murine liver.	TJP2 TJP1	3.26e-05	2	199	2	33184034
Pubmed	Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.	EGFR TNK2	3.26e-05	2	199	2	20359967
Pubmed	Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family.	TEAD1 TEAD4	3.26e-05	2	199	2	8921372
Pubmed	Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion.	TJP1 CDH2	3.26e-05	2	199	2	15855653
Pubmed	ZO-1- and ZO-2-dependent integration of myosin-2 to epithelial zonula adherens.	TJP2 TJP1	3.26e-05	2	199	2	18596233
Pubmed	ZO-1 and ZO-2 are required for extra-embryonic endoderm integrity, primitive ectoderm survival and normal cavitation in embryoid bodies derived from mouse embryonic stem cells.	TJP2 TJP1	3.26e-05	2	199	2	24905925
Pubmed	Filamin isogene expression during mouse myogenesis.	FLNA FLNC	3.26e-05	2	199	2	10679933
Pubmed	FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.	FOXC1 EGFR	3.26e-05	2	199	2	25124473
Pubmed	A novel structural unit in the N-terminal region of filamins.	FLNA FLNC	3.26e-05	2	199	2	24469451
Pubmed	TOX2 regulates human natural killer cell development by controlling T-BET expression.	TBX21 TOX2	3.26e-05	2	199	2	25352127
Pubmed	Epidermal growth factor induces tyrosine phosphorylation and reorganization of the tight junction protein ZO-1 in A431 cells.	TJP2 TJP1	3.26e-05	2	199	2	7542259
Pubmed	Altered expression of ZO-1 and ZO-2 in Sertoli cells and loss of blood-testis barrier integrity in testicular carcinoma in situ.	TJP2 TJP1	3.26e-05	2	199	2	17217619
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	3.26e-05	2	199	2	34156443
Pubmed	The characteristics and roles of β-TrCP1/2 in carcinogenesis.	BTRC FBXW11	3.26e-05	2	199	2	33021036
Pubmed	Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup.	TMEM183A TMEM183BP	3.26e-05	2	199	2	16644869
Pubmed	Effects of the differential expression of ZO-1 and ZO-2 on podocyte structure and function.	TJP2 TJP1	3.26e-05	2	199	2	29845705
Pubmed	MAGUK proteins: structure and role in the tight junction.	TJP2 TJP1	3.26e-05	2	199	2	10966866
Interaction	PCDHA10 interactions	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2	1.89e-11	22	195	8	int:PCDHA10
Interaction	PCDHA8 interactions	TMEM132A ROR2 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.14e-10	55	195	10	int:PCDHA8
Interaction	PCDHA7 interactions	PCDHA12 PCDHA8 PCDHA7 PCDHA4 PCDHA2 EGFR	2.14e-09	14	195	6	int:PCDHA7
Interaction	PCDHA3 interactions	MYCBP2 PCDHA11 PCDHA8 PCDHA6 PCDHA1 ATP13A2	8.16e-07	34	195	6	int:PCDHA3
Interaction	PHLPP1 interactions	ATXN2L EPPK1 NEB UBAP2L PRRC2C AP3D1 BTRC FLNA RTN4 ZDBF2 SF1 EGFR TJP1 ARFGAP1 NBR1	9.23e-07	333	195	15	int:PHLPP1
Interaction	PCDHA1 interactions	PCDHA11 PCDHA8 PCDHA4 PCDHA1	1.03e-06	9	195	4	int:PCDHA1
Interaction	YAP1 interactions	GPHN ATXN2L TRAF6 MARS1 RHBDD2 ZYX HNRNPK KMT2C BRD8 UBAP2L PRRC2C HECW2 TJP2 BTRC FOXC1 FBXW11 FLNA CDV3 RTN4 TEAD1 TEAD4 HNRNPUL1 KMT2D EGFR TJP1 ARFGAP1 EIF3D PARD3	2.46e-06	1095	195	28	int:YAP1
Interaction	TJP1 interactions	GPHN MYCBP2 ZYX HNRNPK GJA3 TJP2 BTRC FLNA FMR1 RTN4 CLDN2 EGFR TJP1 PARD3	3.62e-06	325	195	14	int:TJP1
Interaction	WWTR1 interactions	GPHN ATXN2L GAK MYCBP2 ZYX PRRC2C BTRC FBXW11 CDV3 EP400 TEAD1 TEAD4 KMT2D TJP1 ARFGAP1 PARD3	3.74e-06	422	195	16	int:WWTR1
Interaction	SMG7 interactions	ERCC5 BCL9 ZYX UBAP2L TJP2 BTRC FBXW11 FMR1 ZDBF2 HNRNPUL1 KMT2D EGFR CWF19L1	1.47e-05	319	195	13	int:SMG7
Interaction	DVL1 interactions	GPHN RCOR1 BTRC FLNC ROR2 CCDC88C MLH3 DAAM1 PARD3	1.67e-05	151	195	9	int:DVL1
Interaction	PCDHA4 interactions	PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA4 PCDHA1	2.46e-05	60	195	6	int:PCDHA4
Interaction	PCDHGA10 interactions	PCDHA12 PCDHA11 PCDHA8 PCDHA4	2.94e-05	19	195	4	int:PCDHGA10
Interaction	PCDHA11 interactions	PCDHA12 PCDHA11 PCDHA4 PCDHA1	2.94e-05	19	195	4	int:PCDHA11
Interaction	LONP2 interactions	MAP7D2 FBXW11 PCDHA12 PCDHA11 PCDHA8 PCDHA4	2.98e-05	62	195	6	int:LONP2
Interaction	VASP interactions	GPHN ZYX FAT1 TJP2 APBB1IP CDV3 TEAD4 ARHGAP5 EGFR TJP1 PARD3 NBR1	3.10e-05	294	195	12	int:VASP
Interaction	EGR2 interactions	BCORL1 BCL9 KMT2C EP400 DTX1 PHF12 KMT2D ZNF746 CDH2	4.47e-05	171	195	9	int:EGR2
Interaction	G3BP1 interactions	DHX36 ATXN2L EPPK1 MYCBP2 MARS1 HNRNPK UBAP2L PRRC2C POP1 TJP2 BTRC FLNA FMR1 DTX1 HNRNPUL1 ATAD2 EGFR EIF3D EIF2A ATP1B3 NBR1	6.26e-05	835	195	21	int:G3BP1
Interaction	CTNNA2 interactions	FBXW11 PCDHA8 EGFR TNK2 NBR1 CDH12	6.45e-05	71	195	6	int:CTNNA2
Interaction	FLT3 interactions	EPPK1 MARS1 AP3D1 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	6.61e-05	318	195	12	int:FLT3
Interaction	RAPGEF2 interactions	BRD8 BTRC FBXW11 FLNC FMR1 LAP3 TJP1	7.29e-05	105	195	7	int:RAPGEF2
Interaction	ALG13 interactions	BCL9 ZYX UBAP2L PRRC2C FMR1 ROR2 SF1 KMT2D EGFR	7.55e-05	183	195	9	int:ALG13
Interaction	PCDHA12 interactions	PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA4	8.00e-05	46	195	5	int:PCDHA12
Interaction	TOP3B interactions	VWA5B2 PCSK5 PDE2A EPPK1 PCNX3 MYCBP2 KIAA0319L BCL9 KMT2C FAT1 PSME4 UBAP2L CSAD TMEM132A TIMM22 AP3D1 SEMA6C FLNA FLNC FMR1 EP400 PHF12 ATP13A2 CCDC88C KMT2D SHANK2 TNK2 EIF2A OGA RAI1	8.06e-05	1470	195	30	int:TOP3B
Interaction	DAZL interactions	DHX36 ATXN2L UBAP2L PRRC2C FMR1 HNRNPUL1 SF1 EGFR	8.56e-05	145	195	8	int:DAZL
Interaction	TBC1D3L interactions	TBC1D3L EGFR	9.31e-05	2	195	2	int:TBC1D3L
Interaction	IFNLR1 interactions	TRAF6 TMEM183A BTRC FBXW11 SRBD1	1.09e-04	49	195	5	int:IFNLR1
Interaction	CTNNB1 interactions	ATXN2L TRAF6 BCL9 HNRNPK TJP2 PLEKHA7 BTRC FBXW11 FMR1 EP400 RTN4 API5 TEAD4 CCDC88C ARHGAP5 PTPA KMT2D EGFR TJP1 PARD3 CDH2 TCF7L1 CDH12	1.22e-04	1009	195	23	int:CTNNB1
Interaction	TLX3 interactions	BCL9 KMT2C RCOR1 APBB1IP FOXC1 ROR2 TBX21 POU2AF1 HNRNPUL1 KMT2D TOX2	1.31e-04	291	195	11	int:TLX3
Interaction	RPA4 interactions	ATXN2L ERCC5 KIAA0319L HNRNPK PSME4 PRRC2C TJP2 AP3D1 FLNA XPC SF1 TJP1 ARFGAP1 PARD3	1.36e-04	452	195	14	int:RPA4
Interaction	TBXT interactions	BCL9 HMG20B KMT2C RCOR1 FOXC1 KMT2D ZNF746	1.37e-04	116	195	7	int:TBXT
Interaction	CTNNA1 interactions	ZYX TJP2 PLEKHA7 BTRC FBXW11 FAM110B CCDC88C EGFR TJP1 PARD3 CDH2 CDH12	1.50e-04	347	195	12	int:CTNNA1
Interaction	MAX interactions	FARP2 RCOR1 BRD8 FOXC1 FBXW11 EP400 TEAD1 KMT2D EGFR VPS53	1.74e-04	251	195	10	int:MAX
Interaction	SORBS1 interactions	MYCBP2 ZYX TJP2 ROR2 EGFR TNK2 PARD3	1.97e-04	123	195	7	int:SORBS1
Interaction	GSC interactions	BCORL1 BCL9 HMG20B KMT2C TBX21 KMT2D	2.00e-04	87	195	6	int:GSC
Interaction	NUAK2 interactions	AP3D1 BTRC FBXW11 FLNC NUAK2	2.06e-04	56	195	5	int:NUAK2
Interaction	PAX7 interactions	BCL9 HMG20B KMT2C RCOR1 FOXC1 KMT2D ZNF746	2.07e-04	124	195	7	int:PAX7
Interaction	DDX3X interactions	DHX36 ATXN2L TRAF6 EPPK1 MYCBP2 HNRNPK PSME4 PRRC2C BTRC FBXW11 FMR1 API5 HNRNPUL1 EGFR ZNF746 EIF3D NBR1	2.07e-04	651	195	17	int:DDX3X
Cytoband	Ensembl 112 genes in cytogenetic band chr17q12	TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	6.65e-11	149	200	11	chr17q12
Cytoband	5q31	BRD8 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	9.84e-11	115	200	10	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	BRD8 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	8.67e-07	298	200	10	chr5q31
Cytoband	17q12	TBC1D3F TBC1D3 TBC1D3H TBC1D3C TBC1D3B	7.66e-05	99	200	5	17q12
GeneFamily	Clustered protocadherins	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.98e-10	64	117	9	20
GeneFamily	TEA domain transcription factors	TEAD1 TEAD4	2.47e-04	4	117	2	1183
GeneFamily	Ataxins\|Trinucleotide repeat containing	TOX3 EP400 KMT2D	5.47e-04	25	117	3	775
GeneFamily	WD repeat domain containing\|Xeroderma pigmentosum complementation groups\|Nucleotide excision repair	ERCC5 XPC	1.13e-03	8	117	2	1125
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	BTRC FBXW11	2.20e-03	11	117	2	559
GeneFamily	PHD finger proteins	KMT2C PHF12 KMT2D KAT6B	2.77e-03	90	117	4	88
GeneFamily	CD molecules\|Type II classical cadherins	CDH20 CDH12	3.09e-03	13	117	2	1186
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	EPPK1 MAP7D2 ARX PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	7.34e-07	261	197	12	MM1277
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	MYCBP2 HOXD4 ARX PCDHA13 PCDHA11 PCDHA4 PCDHA2 IGF2	1.14e-06	103	197	8	M1967
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	MYCBP2 HOXD4 ARX PCDHA13 PCDHA12 PCDHA11 PCDHA2 IGF2	1.42e-06	106	197	8	MM1265
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	EPPK1 MAP7D2 ARX PCDHA13 PCDHA12 PCDHA11 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.04e-06	238	197	11	M2020
Coexpression	BENPORATH_SOX2_TARGETS	PCSK5 PCNX3 KIAA0319L WDR81 HMOX1 BCL9 HNRNPK EPM2AIP1 SULF1 FBXW11 HNRNPUL1 ATAD2 MINDY2 DARS2 OGA CDH2 NBR1 TCF7L1	1.19e-05	734	197	18	M3835
Coexpression	SMITH_TERT_TARGETS_UP	ATXN2L IL13RA2 MARS1 RCOR1 XBP1 XPC EGFR CEP57	1.46e-05	145	197	8	M17742
Coexpression	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP	GPHN ATP7A VIT MEFV KMT2C TMEM62 EFHC1 TBC1D3G DMXL2 SLC25A20 TBC1D3C TBC1D3B	4.49e-05	392	197	12	M2131
CoexpressionAtlas	Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	EPPK1 CSAD TBC1D3G TBC1D3K TBC1D3F FLNC TBC1D3 TBC1D3H TBC1D3L TBC1D3D PCDHA13 PCDHA12 PCDHA6 PCDHA4 PCDHA1 TBC1D3C TBC1D3B	1.02e-09	281	195	17	PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05	EPPK1 CSAD TBC1D3G TBC1D3K TBC1D3F FLNC TBC1D3 TBC1D3H TBC1D3L TBC1D3D PCDHA13 PCDHA12 PCDHA6 PCDHA4 PCDHA1 TBC1D3C TBC1D3B	1.02e-09	281	195	17	PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05	TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	1.44e-07	90	195	9	PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05	ADAM9 RHBDD2 EPM2AIP1 EFHC1 SULF1 CSAD TOX3 NID1 TBC1D3G TBC1D3K TBC1D3F SEMA6C FLNC DMXL2 SLC25A20 SLC66A2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ROR2 ARX ZDBF2 TEAD1 TBC1D3C TBC1D3B NUAK2 IGF2 DAAM1 CDH2 NBR1 RAI1	4.15e-06	1466	195	32	PCBC_ratio_ECTO_vs_SC_cfr-2X-p05
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	ADAM9 RHBDD2 EPM2AIP1 FAT1 EFHC1 SULF1 CSAD TMEM132A TOX3 NID1 TBC1D3G TBC1D3K TBC1D3F DMXL2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARX ZDBF2 TBC1D3C TBC1D3B NUAK2 IGF2 DAAM1	1.86e-05	1075	195	25	PCBC_ratio_ECTO_vs_DE_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B RAI1	2.89e-05	213	195	10	PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B RAI1	2.89e-05	213	195	10	PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2	FAT1 BRD8 TOX3 MAP7D2 SLC25A20 RTN4 ARX ZDBF2 SLC35F1 CCDC88C MPHOSPH8 CDH2 TOX2	7.80e-05	395	195	13	Facebase_RNAseq_e8.5_Floor Plate_2500_K2
CoexpressionAtlas	DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05	TBC1D3G TBC1D3K TBC1D3F SLC66A2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B	8.45e-05	242	195	10	PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	TRAF6 TOX3 MAP7D2 FMR1 ARX ZDBF2 SLC35F1 CCDC88C TJP1 MPHOSPH8 CDH2	1.03e-04	298	195	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3	EPHB3 CCDC60 BCORL1 FAP CDH20 SULF1 TBC1D3F ARX PCDHA6 TBC1D3C TBC1D3B NUAK2 FER1L4 CDH2	1.22e-04	471	195	14	ratio_ECTO_vs_SC_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000	SULF1 ADAMTS3 ROR2 PCDHA11 SLC35F1 KAT6B CDH2	1.23e-04	120	195	7	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	BCORL1 BRD8 PRRC2C TOX3 MAP7D2 ARX ZDBF2 SLC35F1 CCDC88C CDH2	1.48e-04	259	195	10	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAG1 FAP SULF1 PRRC2C NID1 ABI3BP IGF2 EGFR SPHKAP DAAM1	1.68e-08	191	200	10	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	FAT1 SULF1 TJP2 FLNC ABI3BP ADAMTS3 ROR2 TEAD4 EGFR	1.66e-07	185	200	9	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 SULF1 FAM110B ROR2 ARX EGFR SPHKAP TOX2	1.73e-07	186	200	9	77592a6397b44b2b59a4fc39d7224dd95343efe6
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	FAT1 SULF1 TJP2 FLNC ABI3BP ADAMTS3 ROR2 EGFR PARD3	1.99e-07	189	200	9	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 ROR2 ARX EGFR SPHKAP PARD3 TOX2	2.08e-07	190	200	9	3b8d1e66ae68c1eee64095e75195d76d97e24026
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	2.08e-07	190	200	9	56cc761e50fddfb5366391518b4d8e16589b6b42
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	2.08e-07	190	200	9	25d4b591f75c26e404a34c42f1742d580af6598d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 ROR2 ARX EGFR SPHKAP PARD3 TOX2	2.08e-07	190	200	9	dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	2.27e-07	192	200	9	f6ec683b2133b3095a1fcc06ca8605cf38f774b5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	2.27e-07	192	200	9	690b3d17c481159bc96b8bc7f6a66b51343ee858
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 SULF1 TOX3 FAM110B ARX EGFR PARD3 TOX2	2.27e-07	192	200	9	67d6230e32d446dcb12047fae2c3f1faa80dd720
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	2.37e-07	193	200	9	294cb5b580bb83fe0eb04f112d5507aac35d4d44
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	2.37e-07	193	200	9	3d3c45d5ff6f3396a1990615aae9fe176e799994
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 ARX EGFR SPHKAP PARD3 TOX2	2.48e-07	194	200	9	5d0b0d8e96f0e0297a4dba70a05d87081a4eb323
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 ARX EGFR SPHKAP PARD3 TOX2	2.48e-07	194	200	9	6ac759828c41ffa974ee82842162caa959351dd1
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 GLRA2 TOX3 FAM110B ARX EGFR PARD3 TOX2	2.70e-07	196	200	9	7af6c5147ac859353504d19727dbe24f63a29dd4
ToppCell	pdx-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ADAM9 FAT1 PSME4 FLNA TEAD1 TEAD4 KMT2D TJP1	2.97e-07	144	200	8	0b94d978262a826c9254145aa98c6c30240243f9
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 TMEM132B ABCC8 TBX21 ARX MYOZ3 ZDBF2 SPHKAP	1.25e-06	174	200	8	ecdff386d7f0bc57c170a2c1f4deae5ba7e431b5
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 TMEM132B ABCC8 ARX MYOZ3 POU2AF1 ZDBF2 SPHKAP	1.48e-06	178	200	8	d3cbdec9d75f076e565baca05ede292cca7758a4
ToppCell	IPF-Epithelial-Mesothelial\|IPF / Disease state, Lineage and Cell class	FAT1 SULF1 FLNC ABI3BP ADAMTS3 ROR2 EGFR CDH2	1.61e-06	180	200	8	1fa54bf4dba72866b2295639d991af639341bc08
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPHN PCSK5 FARP2 SULF1 TOX3 ABI3BP TEAD4 TOX2	1.68e-06	181	200	8	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE2A HOXD4 HECW2 NID1 FLNC DTX1 PKD1L3 SPHKAP	2.06e-06	186	200	8	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 SULF1 TOX3 FAM110B ROR2 EGFR SPHKAP TOX2	2.23e-06	188	200	8	8268574584e5fb869a6cb8bbd7135cd7454a6a25
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	2.41e-06	190	200	8	2f54da2bee411f8868348a4c37034184b8f58a89
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 C8orf34 FAT1 TOX3 FAM110B EGFR PARD3 TOX2	2.51e-06	191	200	8	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 ARX EGFR SPHKAP TOX2	2.92e-06	195	200	8	98ca9f3aa36211dde1e6f7f3817b9418c95e583e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAG1 MYCBP2 NEB PRRC2C ABI3BP ARHGAP5 EGFR DAAM1	2.92e-06	195	200	8	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PCSK5 FAT1 NID1 FLNA ABI3BP ADAMTS13 HHIP SPHKAP	3.40e-06	199	200	8	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 SULF1 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	3.52e-06	200	200	8	ca5401b76ab014080914bf78042d368cf318effa
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 SULF1 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	3.52e-06	200	200	8	70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	3.52e-06	200	200	8	e90155498397524b812c46f2412320230b445bb6
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 SULF1 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	3.52e-06	200	200	8	40286010bd17cf9e34ecd5440953b072ebfae208
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	3.52e-06	200	200	8	7345cc7dc24b9174541a3e68ecac8c4c092be400
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PCSK5 C8orf34 FAT1 CDH20 TOX3 EGFR PARD3 TOX2	3.52e-06	200	200	8	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	3.52e-06	200	200	8	f268cb1bb047e88913a828614b0a77871f5f8814
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP PARD3 TOX2	3.52e-06	200	200	8	5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PCSK5 C8orf34 FAT1 CDH20 TOX3 EGFR PARD3 TOX2	3.52e-06	200	200	8	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PCSK5 FAT1 NID1 FLNA ABI3BP ADAMTS13 HHIP SPHKAP	3.52e-06	200	200	8	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PCSK5 C8orf34 FAT1 CDH20 TOX3 EGFR PARD3 TOX2	3.52e-06	200	200	8	a91345f268f13170c27309333603eb82400c9947
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PCSK5 FAT1 NID1 FLNA ABI3BP ADAMTS13 HHIP SPHKAP	3.52e-06	200	200	8	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 SLCO1C1 HECW2 NID1 ROR2 SPHKAP CDH12	6.59e-06	155	200	7	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C8orf34 TMEM132B ABI3BP ROR2 ZDBF2 TEAD4 CDH12	9.91e-06	165	200	7	6d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C8orf34 TMEM132B ABI3BP ROR2 ZDBF2 TEAD4 CDH12	9.91e-06	165	200	7	84f5597b1bb75f42de9a224196bb8ac198bbe3bf
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA5B2 FAP CDH20 ABCC8 AP3D1 PCDHA6 ARHGAP5	1.03e-05	166	200	7	66026988509e39e41274fa0de738383219e8ff30
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK5 TMEM132B PCDHA12 PCDHA11 PCDHA2 SLC35F1 HEY1	1.07e-05	167	200	7	17c653b46507c8bb85da95836ae72a6015336142
ToppCell	Healthy/Control-Plasmablast\|World / Disease group and Cell class	PLEKHA7 CHAC1 POU2AF1 HPDL ENAM TMEM35B TOX2	1.30e-05	172	200	7	d3bfcf5d936152b71cd90f955f9331709edd979e
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCORL1 NEB PSME4 CDV3 XBP1 POU2AF1 TOX2	1.35e-05	173	200	7	62abaaaf48cabd1423f17fb27c33b75ea88867f4
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCORL1 NEB PSME4 CDV3 XBP1 POU2AF1 TOX2	1.35e-05	173	200	7	09cd878c33534bd476d6a4880f5582076189da8c
ToppCell	Healthy/Control-Plasmablast\|Healthy/Control / Disease group and Cell class	PLEKHA7 POU2AF1 HPDL TG ENAM TMEM35B TOX2	1.40e-05	174	200	7	97d19ef3240a1f648c6befaabb9ce45ad469cbce
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	PCSK5 MYCBP2 CSAD APBB1IP RTN4 GPAM OGA	1.62e-05	178	200	7	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	facs-Heart-RA-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 ZYX APBB1IP FOXC1 CDV3 EP400 HNRNPUL1	1.62e-05	178	200	7	b505e2550860e777535ee95f29c936242fd607f1
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB SULF1 ABI3BP PCDHA2 ATAD2 ATP1B3	1.64e-05	119	200	6	c3f1223356e7f245a460ea5568a223e34e458dc1
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP3K14 ADAMTS13 SRBD1 ATP13A2 HPDL ARHGAP5 TOX2	1.68e-05	179	200	7	dd94ebe69ade6f51b94058abe066216f0de9feda
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SULF1 ABI3BP IGF2 HEY1 TJP1 TOX2	1.81e-05	181	200	7	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE2A HOXD4 HECW2 NID1 FLNC DTX1 SPHKAP	1.81e-05	181	200	7	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	C8orf34 FAT1 ABI3BP ADAMTS3 EGFR PARD3 CDH2	1.87e-05	182	200	7	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	IPF-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	FAT1 SULF1 FLNC ABI3BP ROR2 EGFR CDH2	1.94e-05	183	200	7	7df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCSK5 SULF1 ABI3BP IGF2 HEY1 TJP1 TOX2	1.94e-05	183	200	7	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	LA-11._Adipocyte\|LA / Chamber and Cluster_Paper	MYCBP2 BCKDHB CSAD APBB1IP GPAM SGK2 OGA	1.94e-05	183	200	7	3f9011976782fa8aa95cdd6f00f07a91094d411b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 SULF1 ROR2 ARX EGFR SPHKAP TOX2	2.01e-05	184	200	7	e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK5 EFHC1 ABI3BP ROR2 ADAMTS13 HHIP SPHKAP	2.08e-05	185	200	7	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK5 TMEM132B NID1 ABI3BP ROR2 ADAMTS13 SPHKAP	2.08e-05	185	200	7	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULF1 CHAC1 FOXC1 ABI3BP ZDBF2 HEY1 TJP1	2.15e-05	186	200	7	5d0cd07b6b51e8ce9e1da949f757dc4575ec5752
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 TOX3 FAM110B ARX PARD3 TOX2 TCF7L1	2.23e-05	187	200	7	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 ARX EGFR PARD3 TOX2	2.30e-05	188	200	7	433a25fe52914e07e7ba695881f9bcca2d9467ff
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-Late_pro-B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	APBB1IP DTX1 XBP1 POU2AF1 ENAM CD22 ATP1B3	2.30e-05	188	200	7	1f24bb9cac5e74323ef93770442a869a89e07cf1
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	MYCBP2 CSAD APBB1IP RTN4 GPAM SGK2 OGA	2.30e-05	188	200	7	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 SULF1 ROR2 ARX EGFR SPHKAP TOX2	2.30e-05	188	200	7	3139540a656c0436b2123ea50741ff8d00112165
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	C8orf34 FAT1 TOX3 FAM110B EGFR SPHKAP TOX2	2.38e-05	189	200	7	f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP TOX2	2.38e-05	189	200	7	979b7fa947538aa7ca4a219263da2575869a2caa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VIT SULF1 ABI3BP ADAMTS3 ROR2 MYOZ3 HHIP	2.47e-05	190	200	7	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 ROR2 EGFR SPHKAP PARD3 TOX2	2.47e-05	190	200	7	be2b184a3559da41ba387ae0fdbeb9ae532868a5
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	PCSK5 SULF1 IGF2 EGFR HEY1 TJP1 TOX2	2.55e-05	191	200	7	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	IPF-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	PCSK5 SULF1 ABI3BP IGF2 EGFR HEY1 TOX2	2.64e-05	192	200	7	e911e286da26202853f9650ba3cdefe5a5c9b585
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK5 FAT1 NID1 FLNA ABI3BP SLC35F1 HHIP	2.64e-05	192	200	7	992d08092edbc68c47b945deb8708379738c239a
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	FAT1 TOX3 TEAD1 SHANK2 EGFR TJP1 PARD3	2.64e-05	192	200	7	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP TOX2	2.64e-05	192	200	7	63d1b3efe93e5ff939278ebe40bacb38218ea09b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP TOX2	2.64e-05	192	200	7	342842378c20267c5044bdd622515e8b9f895623
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP TOX2	2.64e-05	192	200	7	bd3fa6c8fcb618db64d11f25cabaf08608957c35
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	C8orf34 PLEKHA7 TEAD1 SHANK2 EGFR PARD3 TCF7L1	2.64e-05	192	200	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	LAM-Endothelial-LymEndo\|LAM / Condition, Lineage and Cell class	IL13RA2 PDE2A NID1 FLNC ABI3BP DTX1 IGF2	2.73e-05	193	200	7	68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NEB CHRND FAM110B FLNC TEAD1 IGF2 EGFR	2.73e-05	193	200	7	02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP TOX2	2.82e-05	194	200	7	52aebb0b563e2c2058e7f0554ae870e47692b163
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT1 TOX3 FAM110B ROR2 EGFR SPHKAP TOX2	2.82e-05	194	200	7	bd06e2b8d8c06cddf2e4f58849b86e09013acae1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GLRA2 TOX3 FAM110B ARX EGFR PARD3 TOX2	2.82e-05	194	200	7	02a9cc821c2b14aa7d0e55661a5fab66364474e1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GPHN FAT1 TOX3 PLEKHA7 TEAD1 SHANK2 PARD3	2.82e-05	194	200	7	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	HOXD4 SULF1 ABI3BP TEAD1 EGFR TJP1 TOX2	2.82e-05	194	200	7	eaeeb84576270cc3fc59002ba33bff9639bb0b02
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	C8orf34 TEAD1 HHIP SHANK2 EGFR TJP1 PARD3	2.91e-05	195	200	7	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CHRND FAT1 TMEM132A TEAD1 IGF2 EGFR CDH2	2.91e-05	195	200	7	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	C8orf34 TEAD1 HHIP SHANK2 EGFR TJP1 PARD3	2.91e-05	195	200	7	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	Control-Endothelial-VE_Arterial\|Control / Disease state, Lineage and Cell class	SULF1 FOXC1 TEAD1 TEAD4 IGF2 HEY1 TOX2	2.91e-05	195	200	7	56c66a3655820961e1390b8f4bcc5618e8d0c5a8
ToppCell	cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PCSK5 SULF1 ABI3BP LAP3 IGF2 HEY1 TOX2	2.91e-05	195	200	7	75db19c0371320ea5fce1d6de8c1b40b1e6a2e58
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 FAT1 SULF1 NID1 ABI3BP EGFR TJP1	3.01e-05	196	200	7	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 FAT1 SULF1 NID1 ABI3BP EGFR TJP1	3.01e-05	196	200	7	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK5 SULF1 ABI3BP IGF2 HEY1 TJP1 TOX2	3.01e-05	196	200	7	cf7f384c1771274e766bab03ecc3dfbd13f2df60
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	DHX36 ATXN2L KMT2C SPTY2D1 AP3D1 XBP1 CCDC88C	3.01e-05	196	200	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	COPD-Stromal\|COPD / Disease state, Lineage and Cell class	FAP SULF1 NID1 ABI3BP IGF2 EGFR PARD3	3.11e-05	197	200	7	d5390d86acaa8c39f1da893e8d2271f9ed2951d7
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	EPHB3 HMOX1 NEB PLEKHA7 DMXL2 TBC1D3L PRICKLE3	3.11e-05	197	200	7	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SULF1 FOXC1 ABI3BP LAP3 IGF2 HEY1 TJP1	3.11e-05	197	200	7	61b1b10a017cbeb17f8529fcae66cba77ee2f115
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCSK5 VIT FAP SULF1 NID1 ABI3BP IGF2	3.11e-05	197	200	7	71786e9432e2d649f5d86f639abb25e7102deb67
Computational	Neighborhood of TERF1	ATXN2L GAK HNRNPK BRD8 POLR2C HNRNPUL1	8.10e-05	67	116	6	MORF_TERF1
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A	STAG1 METTL1 TMEM62 PSME4 UBAP2L SULF1 AP3D1 MAP3K14 SHANK2 MPHOSPH8 KAT6B	6.08e-07	190	190	11	6213_DN
Drug	5279552; Up 200; 22uM; MCF7; HT_HG-U133A_EA	ATXN2L BCORL1 HMOX1 BCL9 NEB UBAP2L PCDHA6 SHANK2 PRICKLE3 OGA	5.14e-06	192	190	10	960_UP
Disease	1,5 anhydroglucitol measurement	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.34e-13	29	189	9	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	5.00e-09	87	189	9	EFO_0004340, EFO_0004765
Disease	neuroticism measurement, cognitive function measurement	ATXN2L STAG1 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PKD1L3 TG OGA CEP57 CDH12 RAI1	1.63e-07	566	189	17	EFO_0007660, EFO_0008354
Disease	post-traumatic stress disorder symptom measurement	SULF1 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.00e-06	82	189	7	EFO_0008535
Disease	vital capacity	EPHB3 PCSK5 ATXN2L BCKDHB C8orf34 SULF1 CHAC1 ADAMTS3 MAP3K14 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 TEAD1 PKD1L3 ATP13A2 HHIP PARD3 CDH2	1.39e-06	1236	189	24	EFO_0004312
Disease	Menkes disease (implicated_via_orthology)	ATP7A BTRC FBXW11	2.56e-06	5	189	3	DOID:1838 (implicated_via_orthology)
Disease	neutrophil count, basophil count	PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.53e-05	224	189	9	EFO_0004833, EFO_0005090
Disease	Abnormality of refraction	TJP2 PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1 API5 HHIP FER1L4 PARD3 CDH2	3.16e-05	673	189	15	HP_0000539
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	4.08e-05	2	189	2	DOID:0080598 (implicated_via_orthology)
Disease	neutrophil count	MYCBP2 BCORL1 RHBDD2 BCL9 HNRNPK FARP2 EFHC1 AP3D1 SEMA6C PCDHA13 PCDHA12 PCDHA11 PCDHA8 PCDHA7 GPAM PCDHA6 PCDHA4 PCDHA2 PCDHA1 TEAD1 TOX2 TCF7L1	8.15e-05	1382	189	22	EFO_0004833
Disease	Growth Disorders	ATP7A HMOX1 IGF2 RAI1	8.18e-05	36	189	4	C0018273
Disease	sexual dimorphism measurement	PCSK5 ATXN2L EPPK1 MARS1 BCKDHB FARP2 CLPTM1 AP3D1 FBXW11 ADAMTS3 RTN4 GPAM ADAMTS13 TEAD1 PKD1L3 ATP13A2 HHIP IGF2 FER1L4	9.66e-05	1106	189	19	EFO_0021796
Disease	Hydrocephalus	WDR81 CCDC88C	1.22e-04	3	189	2	cv:C0020255
Disease	Congenital hydrocephalus	WDR81 CCDC88C	1.22e-04	3	189	2	cv:C0020256
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNA FLNC	1.22e-04	3	189	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNA FLNC	1.22e-04	3	189	2	DOID:0111190 (implicated_via_orthology)
Disease	BMI-adjusted waist circumference, physical activity measurement	BCKDHB FBXW11 ADAMTS3 ATP13A2 HHIP VPS53	1.46e-04	123	189	6	EFO_0007789, EFO_0008002
Disease	Intellectual Disability	STAG1 L2HGDH HNRNPK KMT2C FBXW11 FMR1 SHANK2 EIF2A CDH2 VPS53 RAI1	1.57e-04	447	189	11	C3714756
Disease	Colorectal Carcinoma	GALNS C8orf34 KMT2C FAT1 ABCC8 NID1 FAM110B FLNC SLC66A2 RTN4 HHIP MLH3 IGF2 EGFR	1.86e-04	702	189	14	C0009402
Disease	neuroimaging measurement	VWA5B2 ATXN2L STAG1 PRRC2C TOX3 PLEKHA7 ADAMTS3 ROR2 ATP13A2 TG CCDC88C HHIP IGF2 EGFR PARD3 ATP1B3 CEP57 RAI1	1.90e-04	1069	189	18	EFO_0004346
Disease	Malignant neoplasm of breast	PDE2A BCORL1 HMOX1 HNRNPK CHRND CDH20 POP1 TOX3 MAP7D2 FLNA XBP1 KMT2D EGFR HEY1 PRICKLE3 KAT6B CDH2 TCF7L1	2.01e-04	1074	189	18	C0006142
Disease	Dandy-Walker Syndrome	NID1 FOXC1	2.43e-04	4	189	2	C0010964
Disease	body surface area	PCSK5 PDE2A BCKDHB SLCO1C1 CLPTM1 FBXW11 ADAMTS3 ROR2 TEAD1 ATP13A2 HHIP IGF2 PARD3	2.77e-04	643	189	13	EFO_0022196
Disease	Squamous cell carcinoma of esophagus	KMT2C FAT1 FAT2 KMT2D EGFR	3.72e-04	95	189	5	C0279626
Disease	Malignant Cystosarcoma Phyllodes	FLNA KMT2D	4.03e-04	5	189	2	C0600066
Disease	Phyllodes Tumor	FLNA KMT2D	4.03e-04	5	189	2	C0010701
Disease	Endometrioid carcinoma ovary	NUAK2 TNK2	4.03e-04	5	189	2	C0346163
Disease	fibrinogen measurement, factor VII measurement	ATXN2L STAG1 PKD1L3 PARD3	5.28e-04	58	189	4	EFO_0004619, EFO_0004623
Disease	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	NEB CHRND	6.02e-04	6	189	2	C1854678
Disease	laryngeal carcinoma (is_marker_for)	TRAF6 KMT2C	6.02e-04	6	189	2	DOID:2600 (is_marker_for)
Disease	Intravascular hemolysis	ATP7A HMOX1	6.02e-04	6	189	2	C0235574
Disease	Hemolysis (disorder)	ATP7A HMOX1	6.02e-04	6	189	2	C0019054
Disease	Extravascular Hemolysis	ATP7A HMOX1	6.02e-04	6	189	2	C0312854
Disease	hydrocephalus (is_implicated_in)	WDR81 CCDC88C	6.02e-04	6	189	2	DOID:10908 (is_implicated_in)
Disease	non-alcoholic fatty liver disease, type 2 diabetes mellitus	BCKDHB C8orf34 TMEM132B TJP2 VPS53	7.27e-04	110	189	5	EFO_0003095, MONDO_0005148
Disease	primary biliary cholangitis (biomarker_via_orthology)	HMOX1 SLCO1C1 HHIP	7.53e-04	28	189	3	DOID:12236 (biomarker_via_orthology)
Disease	Childhood Oligodendroglioma	DTX1 HEY1	8.39e-04	7	189	2	C0280475
Disease	Adult Oligodendroglioma	DTX1 HEY1	8.39e-04	7	189	2	C0279070
Disease	Abnormality of the eye	FBXW11 CDH2	8.39e-04	7	189	2	C4316870
Disease	Oligodendroblastoma	DTX1 HEY1	8.39e-04	7	189	2	C0344461
Disease	Mixed Oligodendroglioma-Astrocytoma	DTX1 HEY1	8.39e-04	7	189	2	C0280793
Disease	Mixed Oligodendroglioma-Ependymoma	DTX1 HEY1	8.39e-04	7	189	2	C0751395
Disease	Well Differentiated Oligodendroglioma	DTX1 HEY1	8.39e-04	7	189	2	C0751396
Disease	brain measurement, neuroimaging measurement	VWA5B2 ATXN2L TOX3 ADAMTS3 ATP13A2 TG CCDC88C HHIP EGFR PARD3 ATP1B3	8.90e-04	550	189	11	EFO_0004346, EFO_0004464
Disease	joint damage measurement	ABI3BP MAP3K14 TG VPS53	9.64e-04	68	189	4	EFO_0005413
Disease	urinary albumin to creatinine ratio	WDR81 FAT1 PRRC2C HNRNPUL1 SPHKAP CDH2	1.07e-03	179	189	6	EFO_0007778
Disease	cortical surface area measurement	ATXN2L STAG1 PCNX3 MYCBP2 PRRC2C TOX3 PLEKHA7 ADAMTS3 MAP3K14 ATP13A2 TG CCDC88C HHIP IGF2 EGFR TJP1 DAAM1 PARD3 TCF7L1	1.08e-03	1345	189	19	EFO_0010736
Disease	oligodendroglioma	DTX1 HEY1	1.11e-03	8	189	2	C0028945
Disease	Congenital Hydrocephalus	WDR81 CCDC88C	1.11e-03	8	189	2	C0020256
Disease	triacylglycerol 58:6 measurement	TRAF6 TOX3	1.11e-03	8	189	2	EFO_0010440
Disease	Anaplastic Oligodendroglioma	DTX1 HEY1	1.11e-03	8	189	2	C0334590
Disease	smoking behavior, BMI-adjusted waist circumference	PCSK5 FBXW11 ADAMTS3 ATP13A2 HHIP	1.16e-03	122	189	5	EFO_0004318, EFO_0007789
Disease	esophagus squamous cell carcinoma (is_marker_for)	FAP FAT1 KMT2D EGFR	1.32e-03	74	189	4	DOID:3748 (is_marker_for)
Disease	Parkinsonism (biomarker_via_orthology)	HMOX1 ABCC8 EGFR	1.34e-03	34	189	3	DOID:0080855 (biomarker_via_orthology)
Disease	Spinocerebellar Ataxia Type 2	FOXC1 CCDC88C CWF19L1	1.34e-03	34	189	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	FOXC1 CCDC88C CWF19L1	1.34e-03	34	189	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	FOXC1 CCDC88C CWF19L1	1.34e-03	34	189	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	FOXC1 CCDC88C CWF19L1	1.34e-03	34	189	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	FOXC1 CCDC88C CWF19L1	1.34e-03	34	189	3	C0752124
Disease	Ataxia, Spinocerebellar	FOXC1 CCDC88C CWF19L1	1.34e-03	34	189	3	C0087012
Disease	Todd Paralysis	ATP7A CHRND	1.43e-03	9	189	2	C0234544
Disease	Xeroderma pigmentosum	ERCC5 XPC	1.43e-03	9	189	2	cv:C0043346
Disease	Paralysed	ATP7A CHRND	1.43e-03	9	189	2	C0522224
Disease	Spinocerebellar Ataxia Type 4	FOXC1 CCDC88C CWF19L1	1.46e-03	35	189	3	C0752122
Disease	post-traumatic stress disorder	PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.98e-03	202	189	6	EFO_0001358
Disease	Profound Mental Retardation	STAG1 L2HGDH FMR1 SHANK2 RAI1	2.06e-03	139	189	5	C0020796
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC5 KMT2C FAT1 KMT2D EGFR	2.06e-03	139	189	5	DOID:3908 (is_implicated_in)
Disease	Mental Retardation, Psychosocial	STAG1 L2HGDH FMR1 SHANK2 RAI1	2.06e-03	139	189	5	C0025363
Disease	Mental deficiency	STAG1 L2HGDH FMR1 SHANK2 RAI1	2.06e-03	139	189	5	C0917816
Disease	Colorectal Neoplasms	FAT1 ABCC8 FLNC HHIP MLH3 IGF2 EGFR	2.14e-03	277	189	7	C0009404
Disease	Basal cell carcinoma	ERCC5 XPC	2.16e-03	11	189	2	C0007117
Disease	Bipolar I disorder	XBP1 KAT6B	2.16e-03	11	189	2	C0853193
Disease	Parkinson Disease	GAK HMOX1 ATP13A2 IGF2	2.20e-03	85	189	4	C0030567
Disease	Malignant neoplasm of liver	HMOX1 TOX3 XPC IGF2 TNK2	2.26e-03	142	189	5	C0345904
Disease	Liver neoplasms	HMOX1 TOX3 XPC IGF2 TNK2	2.26e-03	142	189	5	C0023903
Disease	waist-hip ratio	PCSK5 MYCBP2 BCKDHB C8orf34 MEFV ABCC8 NID1 AP3D1 FOXC1 DMXL2 DTX1 MAP3K14 XBP1 ATP13A2 HHIP IGF2 ATP1B3	2.39e-03	1226	189	17	EFO_0004343
Disease	nicotine dependence symptom count	EPHB3 PCSK5 MYCBP2 ABI3BP EGFR PARD3 CDH12	2.51e-03	285	189	7	EFO_0009262
Disease	peptic esophagitis (biomarker_via_orthology)	EGFR TJP1	2.58e-03	12	189	2	DOID:13976 (biomarker_via_orthology)
Disease	Anxiety States, Neurotic	FMR1 TG RAI1	2.82e-03	44	189	3	C0376280
Disease	Anxiety neurosis (finding)	FMR1 TG RAI1	2.82e-03	44	189	3	C1279420
Disease	Anxiety Disorders	FMR1 TG RAI1	2.82e-03	44	189	3	C0003469
Disease	fibrinogen measurement, tissue plasminogen activator measurement	ATXN2L FARP2 PKD1L3	3.01e-03	45	189	3	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	ATXN2L FARP2 PKD1L3	3.01e-03	45	189	3	EFO_0004623, EFO_0004792
Disease	esophagus squamous cell carcinoma (is_implicated_in)	KMT2C FAT1 KMT2D	3.01e-03	45	189	3	DOID:3748 (is_implicated_in)
Disease	bipolar disorder, response to lithium ion	EGFR TCF7L1	3.53e-03	14	189	2	GO_0010226, MONDO_0004985
Disease	response to fenofibrate	PCSK5 APBB1IP SHANK2	4.06e-03	50	189	3	GO_1901557
Disease	generalised epilepsy	HNRNPK AP3D1 PADI6	4.54e-03	52	189	3	EFO_0005917
Disease	2-hydroxyglutarate measurement	L2HGDH STPG4	4.62e-03	16	189	2	EFO_0021506
Disease	Small cell carcinoma of lung	EPHB3 ZDBF2 EGFR	5.05e-03	54	189	3	C0149925
Disease	corneal topography	CHRND ADAMTS3 IGF2 TJP1	5.38e-03	109	189	4	EFO_0004345
Disease	melanoma	ERCC5 TMEM132B GPAM XPC SF1 RAI1	5.41e-03	248	189	6	C0025202
Disease	cortical thickness	VWA5B2 MYCBP2 VIT CDH20 TOX3 PLEKHA7 ADAMTS3 MINDY2 ATP13A2 TG HHIP IGF2 EGFR PARD3 ATP1B3	5.53e-03	1113	189	15	EFO_0004840
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	ATXN2L FARP2 PKD1L3	5.59e-03	56	189	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	borna disease (biomarker_via_orthology)	XBP1 EIF2A	5.84e-03	18	189	2	DOID:5154 (biomarker_via_orthology)
Disease	Adrenocortical carcinoma	IGF2 EGFR	5.84e-03	18	189	2	C0206686
Disease	vitamin D measurement	PLEKHA7 FAM110B ADAMTS3 GPAM SHANK2 RUSC1-AS1 ATP1B3	6.12e-03	336	189	7	EFO_0004631
Disease	Alzheimer's disease (biomarker_via_orthology)	ATP7A ADAM9 IGF2	6.16e-03	58	189	3	DOID:10652 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VDATVNPGPKRPYNF	TMEM62	186	Q0P6H9
NPGPKRPYNFFGILD	TMEM62	191	Q0P6H9
PVQYGQKPEGRTVAF	EP400	1466	Q96L91
PFPGDPYSYNVQDKR	CHRND	501	Q07001
SPFLKPVSERQAPGY	BRD8	1126	Q9H0E9
KPPDGNAPPNSFYRA	BTRC	256	Q9Y297
PNPPRAEFNYSVGFK	APBB1IP	36	Q7Z5R6
KPTGPANIYPRCSVN	BCORL1	806	Q5H9F3
GSKFNQGRPTYPAEP	C8orf34	386	Q49A92
QGRPTYPAEPQAKVT	C8orf34	391	Q49A92
PPEKKSSRNYFGAQP	CEP57	266	Q86XR8
NRYVGFGNTPPPQKK	ARFGAP1	181	Q8N6T3
AGPKRDARQIYNPPS	API5	471	Q9BZZ5
EQFFSDPYRKTPSPN	AMZ2	71	Q86W34
RKPNIFYSGPASPAR	ATAD2	316	Q6PL18
QGYRPPPFSEKFFLV	DMXL2	881	Q8TDJ6
KTPQGPPEIYSDTQF	CDV3	181	Q9UKY7
QNVGPPPKDLTAEVY	C5orf64	46	Q2M2E5
PDITFTYFQPKPRQA	ADAMTS13	671	Q76LX8
KGPPQSPVFEGVYNN	ATXN2L	106	Q8WWM7
KYATPQVIQAPGPRA	TNK2	826	Q07912
SPSPQKRYQDTPGVE	AP3D1	686	O14617
GKAEVRYNPAVIQPP	ATP7A	526	Q04656
PFYASENLRQVPDKP	CCDC60	21	Q8IWA6
KVNPPQDFEIVDPGY	IL13RA2	31	Q14627
RVGPQYQAVVPDFDP	RCOR1	106	Q9UKL0
VPPSRQYAEQGAQVP	RAI1	151	Q7Z5J4
AQDVYAKDNLPPFPA	GPHN	356	Q9NQX3
PPFPASVKDGYAVRA	GPHN	366	Q9NQX3
PQDNTRKPGPAAYNV	ODF3B	211	A8MYP8
AQPEYTVFVKENNPP	PCDHA2	456	Q9Y5H9
AQPEYTVFVKENNPP	PCDHA6	456	Q9UN73
YKDPDNPGRFSSVKP	KAT6B	71	Q8WYB5
YKGSPNANEPPLVFV	LAP3	266	P28838
PGTQRANARAPAPYK	HECW2	1176	Q9P2P5
FQPDPEPREYGQTQK	BCKDHB	56	P21953
AQPEYTVFVKENNPP	PCDHA7	456	Q9UN72
NDNPPTFIPPNYRVK	FAT1	921	Q14517
QPEYTVFVKENNPPG	PCDHA11	456	Q9Y5I1
SDQQPKRSFARPYFP	PADI6	601	Q6TGC4
AQPEYTVFVKENNPP	PCDHA8	456	Q9Y5H6
YRLKQPNVPFPPTSN	KMT2C	4161	Q8NEZ4
PETYPQDIFSNGLKP	MAP7D2	606	Q96T17
VKGNIYPVPDSRFPF	L2HGDH	296	Q9H9P8
NKAVDYPPVANAGPN	KIAA0319L	496	Q8IZA0
KNRVQSGPRTPNPYA	MLEC	251	Q14165
SQEPKDQRPLGTYPD	ALOXE3	646	Q9BYJ1
LAPADPNGKADPYVV	FER1L4	1261	A9Z1Z3
LPQEGAQKRGTAPPY	CCDC88C	1641	Q9P219
EGRPLKPGQYVKPNF	CCDC88C	1741	Q9P219
KQPPDVTENPYRKSG	CWF19L1	256	Q69YN2
EGTAVPPKRPYGTQR	PCNX3	476	Q9H6A9
QPYSPTNEFPKVERF	PCSK5	601	Q92824
PENGPPYSFRITKGN	FAT2	3456	Q9NYQ8
SFKNYVRPGPTRAQE	MLH3	626	Q9UHC1
YPAARPAEPRGQQVF	PDE2A	16	O00408
APYQGPSRDPDQKGK	NID1	161	P14543
LFKNRPTDGPPNSFY	FBXW11	191	Q9UKB1
YGGDPVPKSPFVVNV	FLNC	946	Q14315
PQYDGRTPIKPQQSE	HEATR6	291	Q6AI08
QYKPDSTAAPDQRAP	HEATR6	746	Q6AI08
RFQTAPPGKYPNGFR	SLC25A20	236	O43772
VSGKSPLPPRYAAVN	EPHB3	431	P54753
PGQKECRPFEVYLPS	MEFV	221	O15553
RQQSLYAPKGSVPSP	MED26	286	O95402
PVRRNFYDPSSAPGK	DTX1	91	Q86Y01
LAPPGAYYQQPGKER	HPDL	281	Q96IR7
FREPATINYPFEKGP	NDUFS8	76	O00217
TINYPFEKGPLSPRF	NDUFS8	81	O00217
AQPEYTVFVKENNPP	PCDHA1	456	Q9Y5I3
AQPEYTVFVKENNPP	PCDHA13	456	Q9Y5I0
PLPGARAYSQSDPKQ	HOXD4	106	P09016
VFKPKSEEPYGQLNP	PI4K2B	146	Q8TCG2
QAPAPARPYQGVRVK	POU2AF1	11	Q16633
SQYKRSPNVPGDFPD	POP1	651	Q99575
VPPGLKPEQVYQFFS	PRICKLE3	96	O43900
AQPEYTVFVKENNPP	PCDHA4	456	Q9UN74
EYQKSQPPQPGDKFV	DAAM1	911	Q9Y4D1
HFGPYDNKARPNIPV	GALNS	166	P34059
KPELPRQPGSTAQYD	GAK	751	O14976
SVPKRPAGSVQNPVY	EGFR	1096	P00533
SKGAPFRRPLYTNVP	ATP13A2	1066	Q9NQ11
GPNAYAAFRPNSKPD	ADAMTS3	1111	O15072
DVRFPPPVGYNKDIN	FMR1	46	Q06787
FVPKGSIYAPPNNRF	GCNT7	251	Q6ZNI0
PFNFKPEYAPISVRV	EPM2AIP1	491	Q7L775
VTIKYGGQPVPNFPS	FLNA	1231	P21333
ARAYGPYTPQPQPKD	FOXC1	61	Q12948
NEPKFLDGPYVATVP	CDH20	161	Q9HBT6
YRSQPQLGFKSTPPA	PIK3CD-AS1	116	Q5SR53
EKATPRNFPPRFQDG	DHX36	991	Q9H2U1
PSEKPSQTLQYFPRG	BCL9	1241	O00512
GKERYNFPNPNPFVE	EIF3D	331	O15371
VTFYPQDAPDQPLKA	CHAC1	126	Q9BUX1
LPDNFPRYPVGKFFQ	IGF2	101	P01344
PTYAAKQPQQFPSRP	ADAM9	776	Q13443
FVPPSLRGKQESPDY	CSAD	416	Q9Y600
SGYDARIRPNFKGPP	GLRA2	56	P23416
RSKSYRENGAPFVPP	ARX	171	Q96QS3
PGQPPKVKSEFNSYS	CLDN2	211	P57739
VLTYGQPKQAPPADF	EFHC1	71	Q5JVL4
NKGPDYFRRQAEPNP	FAM110B	31	Q8TC76
ERNKESPVFAPVYFP	HMOX1	66	P09601
PSAPTQAANLGKPYR	HEY1	281	Q9Y5J3
NEPKFLDGPYVATVP	CDH12	156	P55289
APARPPDQKGNQPYY	ENAM	796	Q9NRM1
NDFVLSPGPQPYKVA	EIF2A	171	Q9BY44
LKFGPGVIENPQYPN	FKRP	471	Q9H9S5
QAAERQPPALKAYPA	GJA3	331	Q9Y6H8
VKFFPPDPGQLQEEY	FARP2	121	O94887
VNENPYFAPNPKIIR	CDH2	491	P19022
QRGPGAELDVQYPPK	CD22	406	P20273
FNYKPPQNIPEGSGI	MPHOSPH8	766	Q99549
AQPEYTVFVKENNPP	PCDHA12	456	Q9UN75
VQDPSYAPPKGPFRQ	PARD3	1316	Q8TEW0
VRQYNEEGRKAGPPP	HNRNPUL1	591	Q9BUJ2
GAPYVRNTPQFTKPL	MAP3K14	186	Q99558
LPNGPKAPVTGYVRF	HMG20B	66	Q9P0W2
RPPSDPETVYKGQQD	MINDY2	496	Q8NBR6
PPRPQPAFKYQFVRE	RTN4	16	Q9NQC3
REPGKFYSLPQSPQQ	DARS2	231	Q6PI48
PQGLKEPSINEYSFP	SPHKAP	541	Q2M3C7
YHKRLTPPFNPNVTG	SGK2	301	Q9HBY8
VVPLYGRGSQKPQDP	RNF5	76	Q99942
ASYPPFATQQVVPPR	TMEM132A	96	Q24JP5
PPIINASYGPFSVEK	TMEM132B	81	Q14DG7
AYKALFAGPPVTAQP	NBR1	896	Q14596
EQFVPGPNEKPLYTA	OGA	536	O60502
YEPFAARISKNPAIP	TMEM183BP	211	Q1AE95
SPIKGRAQPYDPNFY	HNRNPK	216	P61978
NFSGPVPEPEYLQKL	GPAM	741	Q9HCL2
GFPNPAVAEAYLKPV	ERCC5	926	P28715
EPQGPPFIKYSTRQA	EPPK1	476	P58107
DAIKSQYQFPPPLIA	PHF12	381	Q96QT6
VPGSRDKNNPVYVAP	PKD1L3	1246	Q7Z443
DKNNPVYVAPAINSP	PKD1L3	1251	Q7Z443
GYQRAFPPRTNPEKH	PLEKHA7	411	Q6IQ23
AKVPYGKGPSFNQER	PRRC2C	386	Q9Y520
FLYRRCKSPPPQGQV	SMIM28	71	A0A1B0GU29
VAILNQKYAPPAFNP	MYCBP2	1981	O75592
QRSTQKDPVPYQPPF	XBP1	231	P17861
QCPFVDVPAGTYPRK	ARHGAP5	726	Q13017
VSNARYVGPKQKAPP	ROR2	781	Q01974
ALQPTPYSQRKGPRE	RUSC1-AS1	41	Q66K80
QISNGAYREPPKPSD	NUAK2	261	Q9H093
PEDKGPKPFRSYNNN	TBC1D3L	31	B9A6J9
VNNVPKRYSLAVGPP	SPTY2D1	16	Q68D10
PDFPRKQVRGPASNY	HHIP	181	Q96QV1
TETYPQGQPVKFPAN	SRBD1	186	Q8N5C6
SQAPYDPNGKPERFY	POLR2C	216	P19387
SPTPRVYGTIKPAFN	SHANK2	911	Q9UPX8
PQGPASKYQAVPLRV	ABCC8	631	Q09428
NDEVPKYRDQIPSPG	ATP1B3	66	P54709
GSVPPPLDQYVKFDA	CLPTM1	256	O96005
YPKAENQTPGREGPQ	PNMA5	411	Q96PV4
YLKQRPGDPPFQITF	FAP	171	Q12884
PYPKAGAKNPVVRIF	FAP	251	Q12884
PEDKGPKPFRSYNNN	TBC1D3B	31	A6NDS4
PEDKGPKPFRSYNNN	TBC1D3H	31	P0C7X1
AQDPRVYKQFRNPSG	SLC35F1	361	Q5T1Q4
DGKDFPIPSPNLYSQ	UHRF1BP1L	511	A0JNW5
APGDSQAVRPYKQEP	ZNF444	146	Q8N0Y2
EPQKAPSRPYQDTRG	TJP2	1141	Q9UDY2
VFPLKVFGYQPDPLN	TMEM35B	46	Q8NCS4
YGPAVFPVAPTSSKQ	UBAP2L	926	Q14157
YEPFAARISKNPAIP	TMEM183A	211	Q8IXX5
PEDKGPKPFRSYNNN	TBC1D3F	31	A6NER0
RRPQDSAFFKGPPYP	TCF7L1	106	Q9HCS4
PDNPPYNKGAFRIEI	UBE2L5	41	A0A1B0GUS4
TPPVDQPSRFGNKAY	PTPA	126	Q15257
AAQSRKLNPVPGSYP	RHBDD2	241	Q6NTF9
PGPGAYTTLRQFPKQ	STPG4	211	Q8N801
RPTIPRNPKGFGYVT	TRAF6	461	Q9Y4K3
SVQPVGRPSFKTEYP	SLCO1C1	16	Q9NYB5
KYLEQPDGASRNPVP	ZDBF2	226	Q9HCK1
QAGETTKAYQRPPIP	VIT	161	Q6UXI7
PPSKDGDAVQTPQLY	SEMA6C	666	Q9H3T2
QKGQEYPPPNLAFLE	STAG1	991	Q8WVM7
PEDKGPKPFRSYNNN	TBC1D3E	31	A0A087X179
DPNEPQKPVSAYALF	TOX3	251	O15405
PGPRGFVPQKEIVYN	PSME4	21	Q14997
DVKPFSQQTYAVQPP	TEAD4	176	Q15561
RFVADFKAQGPPKPN	VPS53	446	Q5VIR6
DKQPYPSRPPFDNQH	TJP1	1096	Q07157
TYRNPQPQPVDGVFV	VWA5B2	36	Q8N398
KPQGNYSVIPPSSRD	ZMYM5	91	Q9UJ78
TNVGFDPKDPYRTPT	TIMM22	96	Q9Y584
DPNEPQKPVSAYALF	TOX2	251	Q96NM4
EAVQAPGYPEPARKA	ZNF843	281	Q8N446
NDPFKARVSSGYVPP	ZYX	161	Q15942
PPSFTYAQQREKPRV	ZYX	311	Q15942
PEDKGPKPFRSYNNN	TBC1D3D	31	A0A087WVF3
QAPRPFNEPCKYPGR	ZNF746	416	Q6NUN9
DVKPFVQQAYPIQPA	TEAD1	171	P28347
YQPPVAVDGKVPRNE	XPC	741	Q01831
NVSPNQYFPLPAEGK	ABI3BP	66	Q7Z7G0
PEDKGPKPFRSYNNN	TBC1D3G	31	Q6DHY5
PEDKGPKPFRSYNNN	TBC1D3	31	Q8IZP1
GPEDSAPQFSKLYPN	SULF1	226	Q8IWU6
GNPNYPYEFSRKVPT	TG	2666	P01266
YLQKQPQPSPAEGRA	MARS1	201	P56192
GQAYAFARHPQKPAP	SLC66A2	246	Q8N2U9
PSPEPIYNSEGKRLN	SF1	81	Q15637
PEDKGPKPFRSYNNN	TBC1D3K	31	A0A087X1G2
PSRFYPDLPGQAKDV	TBX21	366	Q9UL17
PDLPGQAKDVVPQAY	TBX21	371	Q9UL17
RNVAGAEAPPPQKRY	METTL1	6	Q9UBP6
ESPPLSAGNIYQKRP	WDR81	1271	Q562E7
PEDKGPKPFRSYNNN	TBC1D3I	31	A0A087WXS9
PEDKGPKPFRSYNNN	TBC1D3C	31	Q6IPX1
RASIPVFPDTKPYGA	KMT2D	4746	O14686
PSPNDYRNFNKTPVP	MYOZ3	186	Q8TDC0
YRNFNKTPVPFGGPL	MYOZ3	191	Q8TDC0
PPDLPQFIQAKVNAY	NEB	1031	P20929
QKATGYILPPDAVPF	NEB	4221	P20929